A B S T R A C T Intravenous administration of 5-hydroxytryptamine (5-HT) caused a dose-dependent contraction in the lower esophageal sphincter in the opossum. The smallest dose of 5-HT which caused a detectable contraction of the sphincter was 0.5 ug/kg, and a maximal sphincter contraction was produced by a dose of 40 ,ug/kg. Methysergide converted the contractile effect of 5-HT to a dose-dependent fall in the sphincter pressure; maximal inhibition of 77.2 +7.2% of the resting pressure occurred with a dose of 40 Ag/kg. The inhibitory effect of 5-HT was antagonized by tetrodotoxin, 5 MeO-DMT, and 5-HT tachyphylaxis. 5 MeO-DMT enhanced 5-HT-induced contraction of the sphincter. In the presence of 5 MeO-DMT and methysergide, 5-HT still caused a brief contraction of the sphincter; this contraction appeared to be due to stimulation of postganglionic cholinergic neurons as it was antagonized by tetrodotoxin or atropine. Reserpinization caused enhancement of the sphincter contraction by 5-HT. In the reserpinized animals in the presence of methysergide, 5-HT caused a small initial contraction followed by prolonged inhibition; atropine antagonized the initial contraction, while inhibition was antagonized by 5 MeO-DMT. These studies are consistent with the view that 5-HT exerts several different effects on the sphincter. 5-HT causes contraction of the sphincter by its direct action on the muscle and also by stimulation of cholinergic excitatory neurons. In addiReceivedfor publication 16 June 1976 and in revisedform 29 September 1976. tion, 5-HT inhibits the sphincter by stimuilation of nonadrenergic inhibitory neuirons.
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INTRODUCTION
Serotonin or 5-hydroxytryptamine (5-HT)l has been shown to be widely distributed in variouis parts of the gastrointestinal tract in man and animals (1-4). 5 -HT has been localized mainly to enterochromaffin cells, and it has also been demonstrated in the myenteric plexus (1, 2, 5) . The physicological role of 5-HT on the motor function of the gut is not known, but several studies have suggested that 5-HT may play an important role in the modulation of motor activity of the gut (1, 6) , and it has been implicated in the pathogenesis of dumping syndrome (7) , in the action of morphine-like agents on the gut (8) , and in the disturbed gastrointestinal motility in patients with carcinoid syndrome (9) .
The effect of 5-HT on the different parts of the gut is variable. It is known to stimulate small bowel activity in man and animals, but inhibits gastric and colonic motor activity (1, 2, (9) (10) (11) . The effect of 5-HT on gastrointestinal sphincters has not been systematically examined. Clark and Vane (12) reported that 5-HT caused contraction of the lower esophageal sphincter (LES) in the cat. We report here studies which show that 5-HT can activate receptors at at least three different sites to modify the lower esophageal sphincter pressure (LESP) in intact opossunms.
METHODS
The studies were conducted in 49 opossums (Didelphis virginiana). In this species the lower esophageal sphincter, as in man, is composed of smooth muscle fibers (13) . (15) . Unless stated otherwise, drugs were administered as single 30-s boluses followed by flushing with a 2-ml sterile saline soltution. The volumes of drugs varied from 0.2 to 0.8 ml.
Whenever needed, contintuous infuision was carried out with a B. Braun-Melsungen continuous infusion pump (Bronwill Scientific, a division of Will Scientific, Inc., Rochester, N. Y.).
Different doses of 5-HT were given at random, and an interval of at least 30 min elapsedl between two doses. All the responises were measured as the peak effect. Except for the studies oIn the reserpinized animals, the effect of 5-HT was studied before and after the antagonists in the same animals. In this way each animal served as its own control, and the statistical significance was calculated with the paired t test. The LES responsiveness to unrelated agonists was tested after treatment with antagonists. For catecholamine depletion experiments, the animals were treated with intraperitoneal administration of reserpine (3 mg/kg) 48 and 24 h before the experiment as described elsewhere (16) . Such a treatment abolished the effect of tyramine on the LES (16, 17 Influience of methysergide on the effect of 5-HT doseresponse cuirve. The effect of 5-HT on the LES was studied 20 min after the continuous infusion of methysergide was begun. In the presence of meffiysergide, 5-HT instead of prodtucing contraction caused a fall in the sphincter pressure. This fall in sphincter pressture was also dose related (Fig. 3) . The maximal fall of 34.6 ±3.3 mm Hg (77.2±7.2%) occturred with the dose of 40 jug/kg of 5-HT, the same dose which caused maximal produced in the presence of methysergide. In these animals, 5 (Fig. 6) ; the shift of the 5-HT dose-response curve in the presence of 5 MeO-DMT as compared to control was statistically significant (P < 0.05; sign test (21) agent (bethanechol) and an inhibitory agent (isoproterenol) was examined. These restults are stimmarized in Table I . Note that these antagonists did not impair the responsiveness of tlhe LES to bethanechol or to isoproterenol.
Studies in reserpinized animals
Effect of reserpine on LESP. The mean LESP in reserpine-treated animals was 65.0+2.7 mm Hg, and it was 58.5±+1.6 mm Hg in the control animals. This difference was not significant (P > 0.05). These findings are similar to our previous sttsdies (16) in which we also did not find any influience of reserpinization on the LESP.
Influence of reserpine pretreatment on the doseresponse curve of the effect of 5-HT on LESP. As shown in Fig. 9 , reserpinization auigmented the contractile response of the LES to 5-HT at all of the doses tested. There was a significant shift of the dose- ,g/kg 5-HT produced a biphasic response. There was an initial contraction followed by a prolonged inhibition (Fig. 10) . Such studies in four animals showed an initial contraction of 30.0±3.9 mm Hg followed by peak inhibition of 27.5+3.2 mm Hg (Fig. 11) . These results in reserpinized animals were very different from those obtained in nonreserpinized animals, as described earlier.
Influence of atropine and 5 MeO-DMT on the response to 5-HT (Fig. 11) . The initial contraction caused by 5-HT in the presence of methysergide in the reserpinized animals was antagonized by atropine (30 gtg/kg). The sphincter contraction was 30.0±3.9 mm Hg before atropine and 2.5±1.5 mm Hg after atropine (P < 0.01). Atropine did not influence the inhibitory response which followed the initial contraction.
As shown in Fig. 11 , addition of 5 MeO-DMT antagonized the inhibitory component of the effect of 5-HT in these experiments (P < 0.01).
DISCUSSION
The lower esophageal sphincter provides a good model for the study of excitatory and inhibitory effects of
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S. Rattan and R. K. Goyal drugs. The sphincter muscle maintains a basal tone at rest; against this tone, both inhibition and excitation can be easily demonstrated and quantitated. These studies show that contraction of the LES caused by 5-HT is a net effect of stimulation of at least three different receptor sites. A model of the possible location of the 5-HT receptors is summarized in Fig. 12 . According to this model, 5-HT causes contraction by: (a) a direct excitatory effect on the sphincter muscle; (b) an indirect excitatory effect due to stimulation of cholinergic excitatory neurons; and (c) an indirect inhibitory effect due to stimulation of nonadrenergic inhibitory neurons in the LES.
Gaddum and Picarelli (22) suggested that stimulation of the guinea pig ileum by 5-HT was duie to activation of two kinds of receptors for 5-HT, namely a mtuscle receptor and a neural receptor. The muscle receptor was designated as D type because the effect of 5-HT on this receptor was antagonized by Dibenzyline (phenoxybenzamine) (Smith Kline & French Laboratories, Philadelphia, Pa.). On the other hand, neuiral receptor was designated as M type because the effect of 5-HT on this receptor was antagonized by morphine. However, it is now known that both Dibenzyline and morphine exert several nonspecific effects. Therefore, the classification of the 5-HT receptors into D or M types is not currently favored (23) , but it is generally agreed that 5-HT may exert both direct and indirect excitatory effects on the gut muscle. In certain parts of the gut such as duodenum (mouse), the direct effect of 5-HT is more prominent (23) , while in others stuch as guinea pig ileum, the indirect neural effect of 5-HT is predominant (24, 25) . In the LES, 5-HT appears to exert a prominent direct stimulatory effect. LES contraction caused by 5-HT was not antagonized after antagonism of neural activity by tetrodotoxin. It is now generally agreed that methysergide selectivity antagonizes the direct effect of 5-HT on the muscle (26, 27) . Interestingly, methysergide converted the effect of 5-HT from an increase in LESP to a fall in LESP. The evidence for an indirect excitatory effect of 5-HT came from studies in the reserpinized animals. After catecholamine depletion with reserpine, 5-HT caused an initial brief contraction followed by a more sustained contraction of the LES. Treatment with methysergide made the initial contraction obvious, as methysergide converted the sustained contraction to inhibition (Fig. 10) . The residual brief contraction was antagonized by neural block with tetrodotoxin and also by muscarinic antagonism with atropine. These observations suggest that this contraction may be due to stimulation of cholinergic neurons. The excitatory effect of 5-HT on the cholinergic neurons could also be demonstrated when 5-HT was administered in the presence of methysergide and 5 MeO-DMT (27) . In the presence of these two 5-HT receptor antagonists, 5-HT caused LES contraction which was also opposed by tetrodotoxin or atropine. These studies also revealed the inability of both methysergide and 5 MeO-DMT in antagonizing the action of 5 (2, 8, 23) .
Our findings are consistent with the view that 5-HT receptor may be present on the cholinergic neuron, but we cannot exclude the possibility that this effect may be due to stimulation of the sensory receptor organs which may cause a reflex, cholinergically mediated contraction of the LES. 5-HT has been shown to cause stimulation of sensory organs (28, 29) . However, since our studies were done in bilaterally vagotomized animals, a role of vagally mediated reflex contraction by 5-HT can be ruled out. Further studies are needed to define the role of sensory receptor organ stimulation in mediating the action of 5-HT on the LES.
5-HT also exerted a marked inhibitory influence on the LES; this effect was demonstrated only when the predominant direct excitatory effect of 5-HT on the sphincter muscle was antagonized by methysergide. The inhibitory effects of 5-HT on the LES appeared to be neurally mediated effects, as tlhese effects were antagonized by tetrodotoxin (20 (28, 29) to cautse reflex fall in LESP. The afferents from the mechanoreceptors have been shown to be present mainly in the vaguis (28) . We can exclude the participation of the vagus in any stuch reflex, as these studies were done in vagotomized animals, but inivolvement of locally mediated reflex cannot be excltuded. Moreover, ouir studies canniot exclude a possible effect of 5-HT on preganglionic nerve termini-als synapsing with the postganglionic intramural netronis.
Reserpine treatment produced interesting modifications in the effects of 5-HT. It enhanced the excitatory effect of 5-HT, and it also uinmasked the neurally mediated (by cholinergic neuirons) excitatory effect of 5-HT. These effects can be explained in several ways. First, these effects could be due to depletion of catecholamines by reserpine. According to this view, 5-HT may cause release of catecholamines (33, 34) , which may exert an inhibitory influence on the LES. With catecholamine depletion this inhibitory component of the effect of 5-HT is abolished which leads to apparent enhancement of excitatory effects of 5-HT. However, LES possesses alpha adrenergic excitatory and beta adrenergic inhibitory receptors (17, 35) , and catecholamine release from adrenergic neuirons with tyramine leads to contraction, rather than inhibition of the LES (16, 17) . Second, the increased sensitivity to 5-HT may be due to interference of exogenouis 5-HT uptake (36) by the putative tryptamininergic strtucttires in the LES. Third, 5-HT supersensitivity may be duie to increased cholinergic activity associated with reserpine tieatment. Green et al. (37) have shown that reserpine-induiced 5-HT supersensitivity in the guinea pig ileum was duie to increased cholinergic activity, which was different from nonspecific supersensitivity after reserpinization seen in other structuires (36, 38) .
Phenomenon of increased cholinergic activity associated with reserpinization can explain both increased sensitivity of the LES to excitatory effects of 5-HT at all dose levels as well as the unmasking of cholinergically mediated early contraction of the LES.
Further studies are needed to further define the mode of 5-HT supersensitivity after reserpinization.
However, these experiments did help to uinmask excitatory cholinergic neurons in the LES.
These studies have considerable potential physiological and clinical implications. It has been reported that a component of the inhibitory effect of vagal stimtulation of the LES may be noncholinergic, as antagonism of both nicotinic and mtuscarinic receptors does not completely abolish the vagal response (16) . These studies show that 5-HT can inhibit the LES by acting indirectly by stimtulating nonadrenergic neurons. Clinically increased circulating levels of 5-HT occtur in patients witlh carcinoid syndrome (1) . LES fhinction in carcinoid syndrome has not been investigated. However, it is of some interest to note that methysergide therapy in these patients is associated with frequient occurrence of heartbturn (4) . If these stuidies in opossumii are applicable in man, one can provide an explanation for increased f'requency of heartburn in patients treated with methysergide. Methysergide treattment miay cauise considerable fall in sphincter pressure duie to largely unopposed action of 5-HT on the inhibitory neurons.
